Mural Oncology plc
MURA
$2.09
-$0.01-0.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 37.84M | 36.99M | 37.90M | 45.78M | 45.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 135.69M | 138.61M | 138.26M | 160.92M | 173.14M |
| Operating Income | -135.69M | -138.61M | -138.26M | -160.92M | -173.14M |
| Income Before Tax | -147.15M | -130.73M | -128.51M | -151.80M | -166.36M |
| Income Tax Expenses | -- | -- | -- | 1.98M | 6.94M |
| Earnings from Continuing Operations | -147.15 | -130.73 | -128.51 | -153.78 | -173.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -147.15M | -130.73M | -128.51M | -153.78M | -173.30M |
| EBIT | -135.69M | -138.61M | -138.26M | -160.92M | -173.14M |
| EBITDA | -131.93M | -135.10M | -134.75M | -157.66M | -170.00M |
| EPS Basic | -8.58 | -7.67 | -7.58 | -9.14 | -10.35 |
| Normalized Basic EPS | -4.73 | -4.79 | -4.74 | -5.64 | -6.21 |
| EPS Diluted | -8.58 | -7.67 | -7.58 | -9.14 | -10.35 |
| Normalized Diluted EPS | -4.73 | -4.79 | -4.74 | -5.64 | -6.21 |
| Average Basic Shares Outstanding | 68.54M | 68.19M | 67.82M | 67.44M | 67.10M |
| Average Diluted Shares Outstanding | 68.54M | 68.19M | 67.82M | 67.44M | 67.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |